Cytomegalovirus DNA measurement in blood and plasma using Roche lightcycler CMV quantification reagents

Diagnostic Molecular Pathology

Volumn 17, Issue 3, 2008, Pages 166-173

  Tang, Weihua ^a   Elmore, Sandra H ^a   Fan, Hongxin ^b   Thorne, Leigh B ^a   Gulley, Margaret L ^a,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Assay validation; Blood; Cytomegalovirus; DNA; Plasma; Quantitative polymerase chain reaction

Indexed keywords

VIRUS DNA;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DNA EXTRACTION; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS LOAD; ANALYTICAL EQUIPMENT; BLOOD; GENETICS; METHODOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; HUMANS; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 54049098387     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/PDM.0b013e3181599242     Document Type: Article

References (35)

1. Steininger C, Puchhammer-Stockl E, Popow-Kraupp T. Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART). J Clin Virol. 2006;37:1-9.
2. Scanga L, Chaing S, Powell C, et al. Diagnosis of human congenital cytomegalovirus infection by amplification of viral DNA from dried blood spots on perinatal cards. J Mol Diagn. 2006;8:240-245.
3. Pescovitz MD. Benefits of cytomegalovirus prophylaxis in solid organ transplantation. Transplantation. 2006;82:S4-S8.
4. Afessa B, Peters SG. Major complications following hematopoietic stem cell transplantation. Semin Respir Crit Care Med. 2006;27: 297-309.
5. de la Hoz RE, Stephens G, Sherlock C. Diagnosis and treatment approaches of CMV infections in adult patients. J Clin Virol. 2002;25(suppl 2):S1-S12.
6. Wohl DA, Zeng D, Stewart P, et al. Cytomegalovirus viremia, mortality, and end-organ disease among patients with AIDS receiving potent antiretroviral therapies. J Acquir Immune Defic Syndr. 2005;38:538-544.
7. Zamora MR, Davis RD, Leonard C. Management of cytomegalovirus infection in lung transplant recipients: evidence-based recommendations. Transplantation. 2005;80:157-163.
8. Ljungman P, Reusser P, de la Camara R, et al. Management of CMV infections: recommendations from the infectious diseases working party of the EBMT. Bone Marrow Transplant. 2004;33: 1075-1081.
9. Ruell J, Barnes C, Mutton K, et al. Active CMV disease does not always correlate with viral load detection. Bone Marrow Transplant. 2007;40:55-61.
10. The CARI guidelines. CMV disease and kidney transplant: diagnostic tests for cytomegalovirus in renal transplantation. Nephrology (Carlton). 2004;9(suppl 3):S23-S26.
11. Martin-Davila P, Fortun J, Gutierrez C, et al. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value. J Clin Virol. 2005;33:138-144.
12. Sandherr M, Einsele H, Hebart H, et al. Antiviral prophylaxis in patients with haematological malignancies and solid tumours: guidelines of the infectious diseases working party (AGIHO) of the German society for hematology and oncology (DGHO). Ann Oncol. 2006;17:1051-1059.
13. Razonable RR, Emery VC. Management of CMV infection and disease in transplant patients. 27-29 February 2004. Herpes. 2004; 11:77-86.
14. Allice T, Enrietto M, Pittaluga F, et al. Quantitation of cytomegalovirus DNA by real-time polymerase chain reaction in peripheral blood specimens of patients with solid organ transplants: comparison with end-point PCR and pp65 antigen test. J Med Virol. 2006;78:915-922.
15. Yerly S, Perrin L, Van Delden C, et al. Cytomegalovirus quantification in plasma by an automated real-time PCR assay. J Clin Virol. 2007;38:298-303.
16. Caliendo AM, Ingersoll J, Fox-Canale AM, et al. Evaluation of real-time PCR laboratory developed tests using analyte specific reagents (ASRs) for the quantification of cytomegalovirus. J Clin Microbiol. 2007;45:1723-1727.
17. Garrigue I, Boucher S, Couzi L, et al. Whole blood real-time quantitative PCR for cytomegalovirus infection follow-up in transplant recipients. J Clin Virol. 2006;36:72-75.
18. Hanson KE, Reller LB, Kurtzberg J, et al. Comparison of the Digene Hybrid Capture (R) System CMV DNA (version 2.0), Roche CMV UL54 Analyte Specific Reagent, and Qiagen RealArtTM CMV LC PCR Reagent Tests using AcroMetrix OptiQuantTM CMV DNA Quantification Panels and Specimens from Allogeneic Stem Cell Transplant Recipients. J Clin Microbiol. 2007;45: 1972-1973.
19. Piiparinen H, Lautenschlager I. Quantitative TaqMan assay for the detection and monitoring of cytomegalovirus infection in organ transplant patients. Methods Mol Biol. 2006;335:147-156.
20. Sanchez JL, Storch GA. Multiplex, quantitative, real-time PCR assay for cytomegalovirus and human DNA. J Clin Microbiol. 2002;40:2381-2386.
21. Leruez-Ville M, Ouachee M, Delarue R, et al. Monitoring cytomegalovirus infection in adult and pediatric bone marrow transplant recipients by a real-time PCR assay performed with blood plasma. J Clin Microbiol. 2003;41:2040-2046.
22. Guiver M, Fox AJ, Mutton K, et al. Evaluation of CMV viral load using TaqMan CMV quantitative PCR and comparison with CMV antigenemia in heart and lung transplant recipients. Transplantation. 2001;71:1609-1615.
23. Mhiri L, Kaabi B, Houimel M, et al. Comparison of pp65 antigenemia, quantitative PCR and DNA hybrid capture for detection of cytomegalovirus in transplant recipients and AIDS patients. J Virol Methods. 2007;143:23-28.
24. Thorne LB, Civalier C, Booker J, et al. Analytic validation of a quantitative real-time PCR assay to measure CMV viral load in whole blood. Diagn Mol Pathol. 2007;16:73-80.
25. Gulley ML, Fan H, Elmore SH. Validation of Roche LightCycler Epstein-Barr virus quantification reagents in a clinical laboratory setting. J Mol Diagn. 2006;8:589-597.
26. Razonable RR, Brown RA, Wilson J, et al. The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease. Transplantation. 2002;73:968-973.
27. Weinberg A, Schissel D, Giller R. Molecular methods for cytomegalovirus surveillance in bone marrow transplant recipients. J Clin Microbiol. 2002;40:4203-4206.
28. Wada K, Kubota N, Ito Y, et al. Simultaneous quantification of epstein-barr virus, cytomegalovirus, and human herpesvirus 6 DNA in samples from transplant recipients by multiplex real-time PCR assay. J Clin Microbiol. 2007;45:1426-1432.
29. Preiser W, Brink NS, Ayliffe U, et al. Development and clinical application of a fully controlled quantitative PCR assay for cell-free cytomegalovirus in human plasma. J Clin Virol. 2003;26:49-59.
30. Boivin G, Handfield J, Toma E, et al. Expression of the late cytomegalovirus (CMV) pp150 transcript in leukocytes of AIDS patients is associated with a high viral DNA load in leukocytes and presence of CMV DNA in plasma. J Infect Dis. 1999;179:1101-1107.
31. Schafer P, Kuhn JE, Tenschert W, et al. Polymerase chain reaction (PCR) from ficoll-purified polymorphonuclear leukocytes for monitoring cytomegalovirus infections in renal allograft recipients: superior sensitivity and similar specificity compared with plasma PCR. J Infect Dis. 1998;178:1544-1546.
32. Zipeto D, Morris S, Hong C, et al. Human cytomegalovirus (CMV) DNA in plasma reflects quantity of CMV DNA present in leukocytes. J Clin Microbiol. 1995;33:2607-2611.
33. Schafer P, Tenschert W, Schroter M, et al. False-positive results of plasma PCR for cytomegalovirus DNA due to delayed sample preparation. J Clin Microbiol. 2000;38:3249-3253.
34. Jayarama V, Marcello J, Ohagen A, et al. Development of models and detection methods for different forms of cytomegalovirus for the evaluation of viral inactivation agents. Transfusion. 2006;46: 1580-1588.
35. Drew WL, Tegtmeier G, Alter HJ, et al. Frequency and duration of plasma CMV viremia in seroconverting blood donors and recipients. Transfusion. 2003;43:309-313.